dang yong yan

Dr. dang yong yan


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 April 2018 in Clinical Cancer Research
Verified
Journal Article
Closed access
PDF file
QWQingwei Wang
Qingwei Wang
XGXiao Gao
Xiao Gao
TYTong Yu
Tong Yu
LYLei Yuan
Lei Yuan
JDJie Dai
Jie Dai
HLHenry (Xiaotao) James Li
Henry (Xiaotao) James Li
Purpose: Colorectal cancer is one of the most commonly diagnosed cancers closely associated with inflammation and hyperactive growth. We previously demonstrated a regulatory circuit between the proteasome activator REGγ and NF-kappaB (NF-κB) during colon inflammation, known to be important in the development of colitis-associated cancer as well as sporadic colorectal cancer. How the inflammatory microenvironment affects the Hippo pathway during colorectal cancer development is largely unknown. Experimental Design: Here, we used REGγ-deficient colon cancer cell lines, REGγ knockout mice, and human colorectal cancer samples to identify the novel molecular mechanism by which REGγ functions as an oncoprotein in the development of colorectal cancer. Results: REGγ can directly interact with Lats1 and promote its degradation, which facilitates Yes-associated protein (YAP) activation in colon cancer cells. REGγ deficiency significantly attenuated colon cancer growth, associated with decreased YAP activity. Suppression of tumor growth due to REGγ depletion was overcome by constitutively active YAP. Surprisingly, reciprocal activation of the YAP and NF-κB pathways was observed in human colon cancer cells. REGγ overexpression was found in over 60% of 172 colorectal cancer specimens, highly correlating with the elevation of YAP and p65. Postoperative follow-up revealed a significantly lower survival rate in patients with concomitantly high expression of REGγ, YAP, and p-p65. Conclusions: REGγ could be a master regulator during colorectal cancer development to promote YAP signaling and reinforce cross-talks between inflammation and growth pathways, and REGγ might be a new marker for prognosis of colorectal cancer patients. Clin Cancer Res; 24(8); 2015–25. ©2018 AACR.

3 December 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
KLKun Li
Kun Li
QGQunfeng Guo
Qunfeng Guo
JYJun Yang
Jun Yang
HCHui Chen
Hui Chen
KHKewen Hu
Kewen Hu
LLLei Li
Lei Li
FOXD3 is a tumor suppressor of colon cancer by inhibiting EGFR-Ras-Raf-MEK-ERK signal pathway

1 April 2019 in Journal of Dermatological Science
Verified
Journal Article
Closed access
TFTing Fu
Ting Fu
BCBowen Chai
Bowen Chai
YSYuling Shi
Yuling Shi
DYdang yong yan
dang yong yan
XYXiyun Ye
Xiyun Ye

26 June 2019 in Cell Death & Differentiation
Verified
Journal Article
Open access
PDF file
CJChan Jiao
Chan Jiao
LLLin Li
Lin Li
PZPei Zhang
Pei Zhang
LZLi Zhang
Li Zhang
KLKe Li
Ke Li
HLHenry (Xiaotao) James Li
Henry (Xiaotao) James Li
Anaplastic thyroid cancer (ATC) is the most aggressive human thyroid malignancy, characterized by dedifferentiation and resistance to radioiodine therapy. The underlying mechanisms regulating ATC dedifferentiation are largely unknown. Here, we show that REGγ, a noncanonical proteasome activator highly expressed in ATC, is an important regulator of differentiation in ATC cells. Ablation of REGγ significantly restored expression of thyroid-specific genes, enhanced iodine uptake, and improved the efficacy of 131I therapy in ATC xenograft models. Mechanistically, REGγ directly binds to the TGF-β signaling antagonist Smad7 and promotes its degradation, leading to the activation of the TGF-β signal pathway. With gain- and loss-of-function studies, we demonstrate that Smad7 is an important mediator for the REGγ function in ATC cell dedifferentiation, which is supported by expression profiles in human ATC tissues. It seems that REGγ impinges on repression of thyroid-specific genes and promotion of tumor malignancy in ATC cells by activating the TGF-β signal pathway via degradation of Smad7. Thus, REGγ may serve as a novel therapeutic target for allowing radioiodine therapy in anaplastic thyroid cancer patients with poor prognosis.

15 March 2022 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
XPXu Peng
Xu Peng
CWCaibing Wang
Caibing Wang
WXWan Xiang
Wan Xiang
YLYiyi Liang
Yiyi Liang
YLYing Li
Ying Li
DYdang yong yan
dang yong yan

6 February 2020 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
XRXiaolin Ren
Xiaolin Ren
WXWeili Xia
Weili Xia
XPXu Peng
Xu Peng
HSHongyang Shen
Hongyang Shen
XDXing Dai
Xing Dai
DYdang yong yan
dang yong yan